Most Read Articles
4 days ago
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
3 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
Yesterday
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 3 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.

Polypharmacy tied to lower physical, cognitive capability

07 Jun 2018

Polypharmacy at ages 60–64 years and at age 69 years, especially in those with longstanding polypharmacy, is linked to lower physical and cognitive capability, according to a recent study.

Polypharmacy (5–8 prescribed medications) at age 69 years was reported in 18.2 percent of the study cohort, while excessive polypharmacy (9 prescribed medications) was observed in 4.7 percent. Both were associated with poorer physical and cognitive capabilities.

For instance, cross-sectional analysis with fully adjusted linear regression models showed significant impacts of polypharmacy (coefficient, –2.0; 95 percent CI, –2.8 to –1.1) and excessive polypharmacy (coefficient, –2.9; –4.4 to –1.4) on scores in the third edition of Addenbrooke’s Cognitive Examination (ACE-III; p<0.001).

Similar effects were observed for chair rise speed (polypharmacy: coefficient, –2.2; –3.2 to –1.2; excessive polypharmacy: coefficient, –3.7; –5.6 to –1.8; p<0.001) and grip strength (polypharmacy: coefficient, –2.0; –2.8 to –1.1; excessive polypharmacy: coefficient, –3.7; –5.3 to –2.1; p<0.001).

In the longitudinal analysis, participants with polypharmacy at age 60–64 years showed impaired cognitive (word learning task: coefficient, –0.4; –1.3 to –0.5) and physical (chair rise speed: coefficient, –1.2; –2.6 to 0.3) outcomes.

The effect was stronger when polypharmacy was present at both ages 60–64 years and 69 years (word learning task: coefficient, –0.7; –1.4 to 0.0; chair rise speed: coefficient, –2.4; –3.6 to –1.2).

For the present prospective birth cohort study, researchers recruited 2,007 adults (51.2 percent female) with complete medication data at age 69 years. A word learning test, visual search speed task and the ACE-III were used to assess cognitive capability, while the chair rise speed, standing balance time, walking speed and grip strength measures were used to evaluate physical capability.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
3 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
Yesterday
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 3 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.